Overview
Status
Active
Registry date
2001-09-06
Share capital
1 069 582,00 PLN
Registered address
Stępińska 22/30, 00-739 Warszawa, Poland
Electronic delivery address
AE:PL-97673-93876-WHVEG-22
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 195.27mMedianUSD 1.19mAverageUSD 20.98m
Net profit
This companyUSD 5.89mMedianUSD 101.78kAverageUSD 1.28m
Operating costs
This companyUSD 181.89mMedianUSD 1.08mAverageUSD 18.94m
Assets
This companyUSD 130.57mMedianUSD 1.07mAverageUSD 11.99m
Industry
Bank accounts
Registered as a VAT taxpayer on 2004-04-29. Active
38 1600 1462 1849 4518 9000 0018
22 1940 1210 0103 5501 0010 2000
43 1140 1010 0000 3918 5100 1002
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Dec 13, 2021 | Merger registered |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 29, 2017 | Aid for research and development projects: industrial research | —— | MARSZAŁEK MAZOWIECKI | |
| May 29, 2017 | Aid for research and development projects: experimental development | —— | MARSZAŁEK MAZOWIECKI | |
| May 29, 2017 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | —— | MARSZAŁEK MAZOWIECKI |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2016-08-01 | Innowacyjne zestawy chemiczne niezbędnych do precyzyjnej detekcji oraz oznaczania poszczególnych substancji w organizmie człowieka z wykorzystaniem technologii HPLC i LCMS | $501.7K$501,675 | Regionalny Program Operacyjny Województwa Mazowieckiego na lata 2014-2020 | |
| 2016-07-01 | STWORZENIE NOWOCZESNEGO CENTRUM BADAWCZEGO W CELU OPRACOWANIA INNOWACYJNYCH METOD DIAGNOSTYCZNYCH | $499.0K$499,012 | Program Operacyjny Inteligentny Rozwój |
Tenders
37 tenders recorded as contractor: 16 national ($637,516) and 21 EU ($18,297,862).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jul 17, 2026 | Integracja systemu szpitalnego AMMS z systemem LIS Marcel (ALAB) | $17,443$17,443 | Szpital Głogowski | |
| Jul 16, 2026 | Badania histopatologiczne | —— | Górnośląskie Centrum Medyczne Im. Prof. Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach | |
| Jul 8, 2026 | KBL/2/2026 - Konkurs ofert w zakresie realizacji badań diagnostycznych – laboratoryjnych i genetycznych dla Instytutu „CZMP” | $176.7K$176,654 | Instytut Centrum Zdrowia Matki Polki |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Ewa Małkowska — President of the Management Board
Łukasz Fraszka — Attorney-in-fact (sole)
Maciej Władysław Hipsz — Management Board Member
Tomasz Mariusz Łaszkiewicz — Attorney-in-fact (sole)
Manner of representation
Each member of the management board is authorized to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Hans Jakob Limbach (79) | 6,810 | $158,200.97 | 54.756% |
Ewa Małkowska (61) | 1,718 | $39,910.32 | 13.8136% |
Parkstreet Trading & Investments Ag | 3,720 | $86,418.15 | 29.9108% |
Others | 189 | $4,390.60 | 1.5196% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Bogusław Tadeusz Gnatowski (74) | Posiada 100% udziałów w spółce parkstreet trading & investments ag będącą właścicielem 29,91 % udziałów zgłaszanej spółki oraz bezpośrednio 1,52 % udziałów w kapitale | |
Hans Jakob Limbach (79) | Shareholder of a limited liability company, 585660.0 PLN |
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Teldocsp. z o.o. | 3,660.18 USD | 24.3268% | ||
Centrum Diagnostyki Laboratoryjnejsp. z o.o. | 15,934,629.93 USD | 100% | ||
| 202,593.19 USD | 100% |
Capital group
| Name | Ownership |
|---|---|
| 40% | |
UNILAB sp. z o.o | 44% |
| 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| PZU ZdrowieS.A. | $304,464,409.93 | pzuzdrowie.pl | ||
| ScanmedS.A. | $266,523,177.15 | scanmed.pl | ||
| Centrum Medyczne Enel-MedS.A. | $216,569,060.77 | enel.pl | ||
| LUX Med Onkologiasp. z o.o. | $121,974,338.96 | onkologia.luxmed.pl | ||
| Affideasp. z o.o. | $83,623,402.66 | affidea.com | ||
| Szpital Wolski Im. Dr Anny Gostyńskiejsp. z o.o. | $66,853,476.48 | wolski.med.pl | ||
| Nutrimedsp. z o.o. | $64,888,288.93 | nutrimed.pl | ||
| Centrum Medyczne Damiana Holdingsp. z o.o. | $63,969,631.51 | damian.pl | ||
| Szpital Czerniakowskisp. z o.o. | $53,133,134.99 | szpitalczerniakowski.waw.pl | ||
| Szpital Grochowski Im.Dr Med. Rafała Masztakasp. z o.o. | $46,519,561.61 | grochowski.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-08-25 | Share capital change (1,002,000.00 PLN → 1,069,582.00 PLN) | |
| 2010-02-22 | Address change (Sokołowska 7, 01-142, Warszawa → Stępińska 22/30, 00-739, Warszawa) | |
| 2008-12-12 | Share capital change (154,800.00 PLN → 1,002,000.00 PLN) | |
| 2008-09-08 | Share capital change (51,000.00 PLN → 154,800.00 PLN) | |
| 2008-03-25 | Address change (Przasnyska 6a, 01-756, Warszawa → Sokołowska 7, 01-142, Warszawa) |
FAQ
The main business activity of Alab Laboratoria focuses on independent medical laboratory activities.
The company was registered in the Polish National Court Register (KRS) on September 6, 2001.
The headquarters is located at: Stępińska 22/30, 00-739 Warszawa.
The management board includes: Ewa Małkowska (President of the Management Board) and Maciej Władysław Hipsz (Member of the Management Board).
The share capital of the company is PLN 1,069,582 (approx. $288,920).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 195,272,294, representing an increase of 12.4% compared to 2024.
Yes, the company recorded a net profit of USD 5,888,020 in 2025, meaning the company increased its profit by 727.6%.
The largest operating cost category falls under employee remuneration. This category amounted to USD 59,043,319 in 2025, representing 32% of all operating expenses.
Last updated: 2026-09-16